Image of ROTIPHORESE® Gel 40 (19,1), 40% acrylamide/bisacryl. stock solut., 250 ml - Luminix Health

ROTIPHORESE® Gel 40 (19,1), 40% acrylamide/bisacryl. stock solut., 250 ml

€45,70

Catalog nr.: 3030.4

Volume
Value Packs
Quantity
  • American Express
  • Apple Pay
  • Bancontact
  • Google Pay
  • Klarna
  • Maestro
  • Mastercard
  • PayPal
  • Visa

Compliance & Safety Information

GHS06GHS08 Danger

Hazard Statements (H-Phrases)

H301 Toxic if swallowed
H315 Causes skin irritation
H317 May cause an allergic skin reaction
H319 Causes serious eye irritation
H332 Harmful if inhaled
H340 May cause genetic defects
H350 May cause cancer
H361f H361f – No description available
H372 Causes damage to organs through prolonged or repeated exposure

Precautionary Statements (P-Phrases)

P201 P201 – No description available
P280 Wear protective gloves/protective clothing/eye protection/face protection.
P301+P310 P301+P310 – No description available
P302+P352 IF ON SKIN: Wash with plenty of water.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P308+P313 IF exposed or concerned: Get medical advice/attention.

ROTIPHORESE® Gel 40 (19,1), 40% acrylamide/bisacryl. stock solut., ready-to-use, gas stabilised, Density (D) 1,03 g/cm³, Boiling point (bp) ~100 °C, Storage temp. +4 °C, UN-Nr. 3426

Ready-to-use, gas-stabilized ready-to-use acrylamide solutions with different concentrations and ratios of acrylamide to bisacrylamide. The ROTIPHORESE® gel solutions are very easy to use and enable reproducible and high-resolution gel electrophoresis.

Directions for use

ROTIPHORESE® gel solutions can be used for protein and nucleic acid separation in PAGE gels. The high-purity solutions can be combined with any buffer system. During sequencing, they facilitate the preparation of sequencing gels of consistent quality; our fluorescence-free gel solutions are recommended for the use of automatic sequencers.

Please note

The ROTIPHORESE®acrylamide and bisacrylamide solutions from Carl ROTH are produced only from acrylic acid-free substances and are strictly controlled in acrylamide content and pH. Oxidation products are removed from the solution by a selective absorption process. Their new formation and the polymerization of the solution are prevented by stabilizing the solution with inert gas. In order to ensure a high lot-to-lot consistency of our ROTIPHORESE® solutions, each batch is subjected to an electrophoretic test. Fluorescence-free gel solutions are tested for suitability for automatic sequencers.

• For preparing 4-20 % sequencing gels• No tedious dissolving of urea• Prevents acrylamide dusts• Simple handling

Cross linking 5.

Not a medical device / Not an IVD product
Image of ROTIPHORESE® Gel 40 (19,1), 40% acrylamide/bisacryl. stock solut., 250 ml - Luminix Health

ROTIPHORESE® Gel 40 (19,1), 40% acrylamide/bisacryl. stock solut., 250 ml

250 ml / 1 piece

€45,70